115 related articles for article (PubMed ID: 25203777)
21. Exploration of new scaffolds as potential MAO-A inhibitors using pharmacophore and 3D-QSAR based in silico screening.
Shelke SM; Bhosale SH; Dash RC; Suryawanshi MR; Mahadik KR
Bioorg Med Chem Lett; 2011 Apr; 21(8):2419-24. PubMed ID: 21397504
[TBL] [Abstract][Full Text] [Related]
22. Rational design, synthesis and evaluation of chromone-indole and chromone-pyrazole based conjugates: identification of a lead for anti-inflammatory drug.
Shaveta ; Singh A; Kaur M; Sharma S; Bhatti R; Singh P
Eur J Med Chem; 2014 Apr; 77():185-92. PubMed ID: 24631898
[TBL] [Abstract][Full Text] [Related]
23. Trimethyl-4-oxo-4,5,6,7-tetrahydroindazole-1-acetic acid: a new lead compound with selective COX-2 inhibitory activity.
Abdel-Rahman HM; Ozadali K
Arch Pharm (Weinheim); 2012 Nov; 345(11):878-83. PubMed ID: 22907715
[TBL] [Abstract][Full Text] [Related]
24. Structure-based pharmacophore of COX-2 selective inhibitors and identification of original lead compounds from 3D database searching method.
Michaux C; de Leval X; Julémont F; Dogné JM; Pirotte B; Durant F
Eur J Med Chem; 2006 Dec; 41(12):1446-55. PubMed ID: 17030482
[TBL] [Abstract][Full Text] [Related]
25. Interactions of selected indole derivatives with COX-2 and their in silico structure modifications towards the development of novel NSAIDs.
Dileep KV; Remya C; Tintu I; Sadasivan C
J Biomol Struct Dyn; 2014; 32(11):1855-63. PubMed ID: 24053423
[TBL] [Abstract][Full Text] [Related]
26. Diarylheterocycle core ring features effect in selective COX-1 inhibition.
Perrone MG; Vitale P; Malerba P; Altomare A; Rizzi R; Lavecchia A; Di Giovanni C; Novellino E; Scilimati A
ChemMedChem; 2012 Apr; 7(4):629-41. PubMed ID: 22278975
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors.
Zarghi A; Zebardast T; Hakimion F; Shirazi FH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Oct; 14(20):7044-50. PubMed ID: 16798002
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of N-(substituted benzoylamino)-4-ethyl-1,2,3,6-tetrahydropyridines on nitric oxide generation in stimulated raw 264.7 macrophages.
Yoon K; Soliman K; Redda K
Drugs Exp Clin Res; 2002; 28(2-3):83-90. PubMed ID: 12224381
[TBL] [Abstract][Full Text] [Related]
30. Indole based cyclooxygenase inhibitors: synthesis, biological evaluation, docking and NMR screening.
Estevão MS; Carvalho LC; Freitas M; Gomes A; Viegas A; Manso J; Erhardt S; Fernandes E; Cabrita EJ; Marques MM
Eur J Med Chem; 2012 Aug; 54():823-33. PubMed ID: 22796043
[TBL] [Abstract][Full Text] [Related]
31. 3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors.
Brogi S; Papazafiri P; Roussis V; Tafi A
Eur J Med Chem; 2013 Sep; 67():344-51. PubMed ID: 23880359
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Zebardast T; Daraie B; Hedayati M
Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors.
Anana R; Rao PN; Chen QH; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5259-65. PubMed ID: 16635574
[TBL] [Abstract][Full Text] [Related]
34. QSAR analysis of meclofenamic acid analogues as selective COX-2 inhibitors.
Narsinghani T; Chaturvedi SC
Bioorg Med Chem Lett; 2006 Jan; 16(2):461-8. PubMed ID: 16290292
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cyclooxygenase inhibitory activities of some N-acylhydrazone derivatives of isoxazolo[4,5-d]pyridazin-4(5H)-ones.
Unsal-Tan O; Ozden K; Rauk A; Balkan A
Eur J Med Chem; 2010 Jun; 45(6):2345-52. PubMed ID: 20207453
[TBL] [Abstract][Full Text] [Related]
36. Analogue-based design, synthesis and docking of non-steroidal anti-inflammatory agents. Part 2: methyl sulfanyl/methyl sulfonyl substituted 2,3-diaryl-2,3-dihydro-1H-quinazolin-4-ones.
Manivannan E; Chaturvedi SC
Bioorg Med Chem; 2012 Dec; 20(24):7119-27. PubMed ID: 23146282
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and cycloxygenase inhibitory properties of new naphthalene-methylsulfonamido, naphthalene-methylsulfonyl and tetrahydronaphthalen-methylsulfonamido compounds.
Nencetti S; Ciccone L; Rossello A; Nuti E; Milanese C; Orlandini E
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):406-12. PubMed ID: 25089708
[TBL] [Abstract][Full Text] [Related]
38. Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints.
Hsu N; Cai D; Damodaran K; Gomez RF; Keck JG; Laborde E; Lum RT; Macke TJ; Martin G; Schow SR; Simon RJ; Villar HO; Wick MM; Beroza P
J Med Chem; 2004 Sep; 47(20):4875-80. PubMed ID: 15369391
[TBL] [Abstract][Full Text] [Related]
39. Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors.
Moussa N; Hassan A; Gharaghani S
Heliyon; 2021 Apr; 7(4):e06605. PubMed ID: 33889764
[TBL] [Abstract][Full Text] [Related]
40. Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies.
Reddy KK; Singh SK; Tripathi SK; Selvaraj C
SAR QSAR Environ Res; 2013; 24(7):581-95. PubMed ID: 23521430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
